ARx provides FDA-registered manufacturing facilities with a proven capacity to deliver quality pharmaceutical products commercially.
ARx ensures seamless scale-up and commercial production of transdermal and dissolvable drug delivery systems, leveraging decades of expertise in FDA-approved manufacturing. With over 100 million patch and film units produced annually, we provide high-precision, high-throughput production tailored to the needs of complex formulations.
Our 47,000+ square-foot, FDA-approved, and DEA-registered facility in Glen Rock, PA, integrates polymer processing, coating, lamination, die-cutting, and final packaging under strict cGMP compliance. We partner with you to optimize batch consistency, enhance product stability, and streamline supply chain logistics, ensuring reliable delivery from clinical to commercial scale.
Proven Scale-Up Capacity: Manufacturing systems that scale over 300x from development to commercial production.
Supply Chain Security: Production capacity is continuously monitored to accommodate market fluctuations with flexible batch sizes into the millions.
Regulatory Confidence: Complete cGMP manufacturing under 21 CFR Part 211.
End-to-End Solutions: Comprehensive capabilities, including packaging and serialization, performed on-site—reducing supply chain complexity.
Lifecycle Partnership: Ongoing process optimization and integration maximize your product’s potential.
Our commercial manufacturing ensures consistent, high-quality production from launch through supply. We support oral thin films, sublingual films, buccal thin films, transdermal patches, and topical patches—all with customizable release profiles.
ARx provides comprehensive manufacturing solutions with multiple GMP production lines designed to incorporate active pharmaceutical ingredients with exceptional precision and reliability.
Interested in how novel drug delivery systems compare to traditional methods?
Explore their unique advantages and identify the best fit for your formulation needs.
At ARx, we collaborate closely with our biopharma and biotech partners to help them reach—and exceed—their goals through novel, effective delivery systems.
